By MATTHEW PERRONE

WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on deceptive drug ads, but the effort is likely to face multiple headwinds, including pushback from industry and layoffs among regulators tasked with leading the effort.

Related Articles

Trump administration cuts grants for minority-serving colleges, declaring them unconstitutional

Politicians who have experienced violence react to Charlie Kirk shooting

Charlie Kirk, 31, helped build support for Trump among young people

Trump’s deportation plans result in 320,000 fewer immigrants and slower population growth, CBO says

Trump administration appeals ruling blocking him from firing Federal Reserve Gov. Cook

President Donald Trump signed a memo Tuesday

See Full Page